http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102596201-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
filingDate 2010-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e89580629874586d11c80251b17aaf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_238fb82b516f699768a1676c0e16d475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be1587154852b84aedf284cb99e33cd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac0cfc63c45d1e7534618413a84340ef
publicationDate 2012-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102596201-A
titleOfInvention Medication regimen for HCV combination therapy comprising BI201335, interferon alfa and ribavirin
abstract The present invention relates to a therapeutic combination comprising (a) compound (1) as described herein or a pharmaceutically acceptable salt thereof, (b) interferon-alpha and (c) regenerative medicine, and a specific regimen for administering the combination. barvelin. Compound (1) is a selective and potent inhibitor of HCV NS3 serine protease. The invention also relates to methods of using the therapeutic combination to treat HCV infection or to alleviate one or more symptoms of HCV infection in a patient.
priorityDate 2009-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467305589

Total number of triples: 23.